The renin-angiotensin system and prevention of age-related functional decline: where are we now?

被引:30
|
作者
Simon, Corey B. [1 ]
Lee-McMullen, Brittany [2 ]
Phelan, Dane [3 ]
Gilkes, Janine [4 ]
Carter, Christy S. [5 ]
Buford, Thomas W. [5 ,6 ]
机构
[1] Univ Florida, Pain Res & Intervent Ctr Excellence, Gainesville, FL USA
[2] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL USA
[3] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA
[4] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA
[5] Univ Florida, Coll Med, Dept Aging & Geriatr Res, Gainesville, FL 32611 USA
[6] Univ Florida, Dept Appl Physiol & Kinesiol, Coll Hlth & Human Performance, Gainesville, FL USA
关键词
Angiotensin; Receptor; Function; Muscle; Genetics; CONVERTING ENZYME-INHIBITORS; EXERCISE-INDUCED CHANGES; SKELETAL-MUSCLE; OLDER-ADULTS; RECEPTOR BLOCKADE; PHYSICAL FUNCTION; INSERTION/DELETION GENOTYPE; HYPERTENSIVE PATIENTS; RUNNING PERFORMANCE; I/D POLYMORPHISM;
D O I
10.1007/s11357-015-9753-5
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Declining physical function is a major health problem for older adults as it is associated with multiple comorbidities and mortality. Exercise has been shown to improve physical function, though response to exercise is variable. Conversely, drugs targeting the renin-angiotensin system (RAS) pathway, including angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs), are also reported to improve physical function. In the past decade, significant strides have been made to understand the complexity and specificity of the RAS system as it pertains to physical function in older adults. Prior findings have also determined that interactions between antihypertensive medications and exercise may influence physical function above and beyond either factor alone. We review the latest research on RAS, exercise, and physical function for older adults. We also outline future research aims in this area, including genetic influences and clinical phenotyping, for the purpose of maintaining or improving physical function through tailored treatments.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 50 条
  • [41] Functional analysis of the renin-angiotensin system in transgenic animal models
    Ganten, D
    Bader, M
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2000, 78 (03): : B5 - B5
  • [42] Evidence for the existence of a functional cardiac renin-angiotensin system in humans
    Serneri, GGN
    Boddi, M
    Coppo, M
    Chechi, T
    Zarone, N
    Moira, M
    Poggesi, L
    Margheri, M
    Simonetti, I
    CIRCULATION, 1996, 94 (08) : 1886 - 1893
  • [43] The renin-angiotensin system - a functional 'jack-of-all-trades'
    Schmerbach, K.
    Patzak, A.
    ACTA PHYSIOLOGICA, 2012, 205 (04) : 453 - 455
  • [44] Evidence for the existence of a functional cardiac renin-angiotensin system in humans
    Danser, AHJ
    vanKats, JP
    Verdouw, PD
    Schalekamp, MADH
    CIRCULATION, 1997, 96 (10) : 3795 - 3795
  • [45] Brain renin-angiotensin system - Lessons from functional genomics
    Baltatu, O
    Bader, M
    NEUROENDOCRINOLOGY, 2003, 78 (05) : 253 - 259
  • [46] THE TISSUE RENIN-ANGIOTENSIN SYSTEM AND ITS FUNCTIONAL-ROLE
    JOHNSTON, CI
    BURRELL, LM
    PERICH, R
    JANDELEIT, K
    JACKSON, B
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1992, : 1 - 5
  • [47] THE RENIN-ANGIOTENSIN SYSTEM IN THE BRAIN - LOCALIZATION AND FUNCTIONAL-SIGNIFICANCE
    PAUL, M
    BADER, M
    STECKELINGS, UM
    VOIGTLANDER, T
    GANTEN, D
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1993, 43-1 (2A): : 207 - 213
  • [48] EFFECTS OF LOW DOSE ANGIOTENSIN II BLOCKADE ON AGE-RELATED FUNCTIONAL DECLINE AND ADIPOSITY
    Carter, C.
    Seo, D.
    DuPree, J.
    Morgan, D.
    GERONTOLOGIST, 2008, 48 : 500 - 500
  • [49] Downregulation of ACE2 induces overstimulation of the renin-angiotensin system in COVID-19: should we block the renin-angiotensin system?
    Silhol, Francois
    Sarlon, Gabrielle
    Deharo, Jean-Claude
    Vaisse, Bernard
    HYPERTENSION RESEARCH, 2020, 43 (08) : 854 - 856
  • [50] Reply to comments on "Is sarcopenia primarily age- or renin-angiotensin system-related disorder?"
    Mogi, Masaki
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2020, 20 (10) : 1000 - 1000